fda glp-1 compounding enforcement news is short-sighted on GLP-1s FDA and Novo Nordisk Warn

Starting to plateau on a GLP-1 can mess with your head fast...the scale stops moving, motivation drops, and its easy to wonder whether the medication stopped working or whether youre doing something wrong

[How It Works]

Glucagon-like peptide-1 receptor agonist (GLP-1RAs) and more recently Twin-Cretins (GLP+GIP) are frequently used for patients with diabetes and associated obesity

This acceleration coincided with surging demand for semaglutide and tirzepatide, two therapies that have become synonymous with the new era of diabetes and obesity treatment

Aims/hypothesis Insulin-like peptide-5 (INSL5) is found only in distal colonic L cells, which co-express glucagon-like peptide-1 (GLP-1) and peptide YY (PYY)